$903 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 55 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 47.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Buy | MERCK & CO INC | $57,329,000 | -0.7% | 973,832 | +5.3% | 6.35% | +12.1% |
| PFE | Buy | PFIZER INC | $57,306,000 | -0.1% | 1,764,343 | +4.2% | 6.35% | +12.7% |
| LLY | Buy | ELI LILLY & CO | $53,627,000 | +10.0% | 729,117 | +20.0% | 5.94% | +24.1% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $40,766,000 | +7.1% | 492,100 | +19.6% | 4.52% | +20.9% |
| ACAD | Buy | ACADIA PHARMACEUTICALS | $33,932,000 | +1808.4% | 1,176,543 | +2004.8% | 3.76% | +2048.0% |
| NUVA | Buy | NUVASIVE INC | $33,592,000 | +180.0% | 498,689 | +177.1% | 3.72% | +215.9% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL | $32,771,000 | +141.1% | 2,104,756 | +198.2% | 3.63% | +171.9% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS | $31,851,000 | -1.2% | 1,419,404 | +0.0% | 3.53% | +11.5% |
| DXCM | Buy | DEXCOM INC | $30,437,000 | +8.0% | 509,836 | +58.6% | 3.37% | +21.9% |
| ACHC | Buy | ACADIA HEALTHCARE | $29,340,000 | +2.7% | 886,405 | +53.7% | 3.25% | +15.9% |
| ISRG | Buy | INTUITIVE SURGIC INC | $26,899,000 | +31.1% | 42,416 | +49.8% | 2.98% | +47.9% |
| TDOC | Buy | TELADOC INC | $25,903,000 | -8.1% | 1,569,878 | +2.0% | 2.87% | +3.7% |
| FOLD | Buy | AMICUS THERAPEUTICS | $25,348,000 | -18.3% | 5,100,198 | +21.6% | 2.81% | -7.8% |
| BIIB | New | BIOGEN INC | $24,059,000 | – | 84,841 | +100.0% | 2.66% | – |
| AET | New | AETNA INC | $22,593,000 | – | 182,185 | +100.0% | 2.50% | – |
| KITE | Buy | KITE PHARMA INC | $16,690,000 | +156.8% | 372,223 | +220.0% | 1.85% | +189.8% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS | $16,268,000 | -31.6% | 1,125,801 | +9.1% | 1.80% | -22.8% |
| ARAY | Buy | ACCURAY INC | $14,134,000 | +19.6% | 3,072,536 | +65.7% | 1.57% | +35.0% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS | $13,923,000 | -20.9% | 669,351 | +24.6% | 1.54% | -10.8% |
| Buy | NEURODERM LTD | $9,786,000 | +226.7% | 440,799 | +172.1% | 1.08% | +268.7% | |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS | $8,056,000 | -30.7% | 74,150 | +5.0% | 0.89% | -21.8% |
| EVHC | New | ENVISION HEALTHCARE | $7,914,000 | – | 125,040 | +100.0% | 0.88% | – |
| XENT | Buy | INTERSECT ENT INC | $6,473,000 | +143.1% | 534,937 | +218.1% | 0.72% | +174.7% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS | $5,711,000 | +37.6% | 379,500 | +6.9% | 0.63% | +55.5% |
| ADXS | Buy | ADVAXIS INC | $4,941,000 | +5.8% | 690,074 | +58.0% | 0.55% | +19.4% |
| RARX | New | RA PHARMACEUTICALS | $3,842,000 | – | 252,940 | +100.0% | 0.43% | – |
| KTWO | New | K2M GROUP HOLDINGS | $3,115,000 | – | 155,450 | +100.0% | 0.34% | – |
| AGIO | Buy | AGIOS PHARMACEUTICALS | $2,291,000 | -17.7% | 54,900 | +4.2% | 0.25% | -7.0% |
| SAGE | New | SAGE THERAPEUTICS | $1,425,000 | – | 27,899 | +100.0% | 0.16% | – |
| INSM | New | INSMED INC | $1,367,000 | – | 103,300 | +100.0% | 0.15% | – |
| SRPT | New | SAREPTA THERAPEUTICS | $790,000 | – | 28,799 | +100.0% | 0.09% | – |
| New | TRILLIUM THERAPEUTICS | $565,000 | – | 100,000 | +100.0% | 0.06% | – | |
| PRFMF | New | PROFOUND MEDICAL | $414,000 | – | 495,900 | +100.0% | 0.05% | – |
| New | PRONAI THERAPEUTICS | $367,000 | – | 201,660 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 45 | Q2 2024 | 6.7% |
| DR REDDYS LABS LTD | 45 | Q2 2024 | 2.0% |
| PTC THERAPEUTICS INC | 43 | Q2 2024 | 2.7% |
| GILEAD SCIENCES INC | 41 | Q2 2024 | 8.4% |
| VERTEX PHARMACEUTICL | 41 | Q2 2024 | 6.0% |
| INCYTE CORPORATION | 41 | Q2 2024 | 5.2% |
| AMICUS THERAPEUTICS INC | 40 | Q2 2024 | 6.6% |
| PFIZER INC | 38 | Q2 2024 | 6.3% |
| MERCK & CO. INC | 37 | Q2 2024 | 6.4% |
| MEDTRONIC PLC | 36 | Q2 2024 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | February 14, 2024 | 2,382,644 | 3.7% |
| Galera Therapeutics, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-13 |
| N-PX | 2024-08-09 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.